Drx Choice Syrup
NDC Package 68163-743-04

11-digit billing NDC: 68163074304
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Drx Choice (guaifenesin) syrups is •do not take more than 6 doses in any 24-hour period•measure only with dosing cup provided•keep dosing cup with product•mL = milliliter•this adult product is not intended for use in children under 12 years of ageagedoseadults and children 12 years and over10 – 20 mL every 4 hourschildren under 12 yearsdo not use. This formulation utilizes a syrup delivery system. Marketed by Raritan Pharmaceuticals Inc, this product is identified by NDC 68163-743 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
68163-743-04
Package Description
1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE
Product Code
68163-743
11-Digit Billing Format
68163074304
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Drx Choice Fruit Punch
Non-Proprietary Name
Guaifenesin
Substance Name
Guaifenesin
Dosage Form
Syrup - An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
GUAIFENESIN 200 mg/10mL
Pharmacologic Class
Usage Information
•do not take more than 6 doses in any 24-hour period•measure only with dosing cup provided•keep dosing cup with product•mL = milliliter•this adult product is not intended for use in children under 12 years of ageagedoseadults and children 12 years and over10 – 20 mL every 4 hourschildren under 12 yearsdo not use

Regulatory & Marketing

Labeler Name
Raritan Pharmaceuticals Inc
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-15-2019
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68163-743-04 identifies a specific commercial package of 1 bottle in 1 carton / 118 ml in 1 bottle of Drx Choice Fruit Punch, a human over the counter drug labeled by Raritan Pharmaceuticals Inc. This syrup is formulated for oral use and contains guaifenesin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Raritan Pharmaceuticals Inc on May 15, 2019. The current certification is valid through December 31, 2027.

How is this Raritan Pharmaceuticals Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68163074304. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
68163-743-04
11-Digit CMS (5-4-2)
68163-0743-04

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.